These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23955332)

  • 1. Three-dimensional culture using human plasma-medium gel with fragmin/protamine microparticles for proliferation of various human cells.
    Kishimoto S; Ishihara M; Takikawa M; Takikawa M; Sumi Y; Nakamura S; Fujita M; Sato T; Kiyosawa T
    Cytotechnology; 2014 Oct; 66(5):791-802. PubMed ID: 23955332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of inbred adipose-derived stromal cells in rats with plasma gel containing fragmin/protamine microparticles and FGF-2.
    Sumi Y; Ishihara M; Kishimoto S; Takikawa M; Doumoto T; Azuma R; Nakamura S; Hattori H; Fujita M; Kiyosawa T
    J Biomed Mater Res B Appl Biomater; 2013 Jul; 101(5):784-91. PubMed ID: 23359413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional expansion using plasma-medium gel with fragmin/protamine nanoparticles and fgf-2 to stimulate adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells.
    Kishimoto S; Ishihara M; Mori Y; Takikawa M; Sumi Y; Nakamura S; Sato T; Kiyosawa T
    Biores Open Access; 2012 Dec; 1(6):314-23. PubMed ID: 23514899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media.
    Kishimoto S; Nakamura S; Nakamura S; Kanatani Y; Hattori H; Tanaka Y; Harada Y; Tagawa M; Mori Y; Maehara T; Ishihara M
    Artif Organs; 2009 Jun; 33(6):431-8. PubMed ID: 19473138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion and characterization of human bone marrow-derived mesenchymal stem cells cultured on fragmin/protamine microparticle-coated matrix with fibroblast growth factor-2 in low serum medium.
    Kishimoto S; Hattori H; Nakamura S; Amano Y; Kanatani Y; Tanaka Y; Mori Y; Harada Y; Tagawa M; Ishihara M
    Tissue Eng Part C Methods; 2009 Sep; 15(3):523-7. PubMed ID: 19191666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective wound healing in streptozotocin-induced diabetic rats by adipose-derived stromal cell transplantation in plasma-gel containing fragmin/protamine microparticles.
    Sumi Y; Ishihara M; Kishimoto S; Takikawa M; Hattori H; Takikawa M; Azuma R; Nakamura S; Fujita M; Kiyosawa T
    Ann Plast Surg; 2014 Jan; 72(1):113-20. PubMed ID: 24317245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilization, stabilization, and activation of human stem cell factor (SCF) on fragmin/protamine microparticle (F/P MP)-coated plates.
    Kishimoto S; Oonuma F; Nakamura S; Hattori H; Nakamura S; Mori Y; Tanaka Y; Harada Y; Tagawa M; Ishihara M
    J Biomed Mater Res B Appl Biomater; 2010 Jan; 92(1):32-9. PubMed ID: 19637375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles.
    Takikawa M; Nakamura S; Nakamura S; Nambu M; Ishihara M; Fujita M; Kishimoto S; Doumoto T; Yanagibayashi S; Azuma R; Yamamoto N; Kiyosawa T
    J Biomed Mater Res B Appl Biomater; 2011 May; 97(2):373-80. PubMed ID: 21432994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective expansion of human adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells cultured on a fragmin/protamine nanoparticles-coated substratum with human platelet-rich plasma.
    Kishimoto S; Ishihara M; Mori Y; Takikawa M; Hattori H; Nakamura S; Sato T
    J Tissue Eng Regen Med; 2013 Dec; 7(12):955-64. PubMed ID: 22473706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization.
    Nakamura S; Kishimoto S; Nakamura S; Nambu M; Fujita M; Tanaka Y; Mori Y; Tagawa M; Maehara T; Ishihara M
    J Biomed Mater Res A; 2010 Mar; 92(4):1614-22. PubMed ID: 19437440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system.
    Nakamura S; Ishihara M; Takikawa M; Kishimoto S; Isoda S; Fujita M; Sato M; Maehara T
    Tissue Eng Part A; 2012 Nov; 18(21-22):2239-47. PubMed ID: 22655590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
    Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
    J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced healing of mitomycin C-treated healing-impaired wounds in rats with PRP-containing fragmin/protamine microparticles (PRP&F/P MPs).
    Takikawa M; Ishihara M; Takabayashi Y; Sumi Y; Takikawa M; Yoshida R; Nakamura S; Hattori H; Yanagibayashi S; Yamamoto N; Kiyosawa T
    J Plast Surg Hand Surg; 2015 Oct; 49(5):268-274. PubMed ID: 25865260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of stem cell factor and granulocyte macrophage-colony stimulating factor on survival of porcine type A spermatogonia cultured in KSOM.
    Dirami G; Ravindranath N; Pursel V; Dym M
    Biol Reprod; 1999 Jul; 61(1):225-30. PubMed ID: 10377053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of platelet-rich plasma-containing fragmin/protamine microparticles in enhancing endothelial and smooth muscle cell growth and inducing collateral vessels in a rabbit model of hindlimb ischemia.
    Fujita M; Horio T; Kishimoto S; Nakamura S; Takikawa M; Nakayama T; Yamamoto Y; Shimizu M; Hattori H; Tachibana S; Ishihara M
    J Biomed Mater Res B Appl Biomater; 2013 Jan; 101(1):36-42. PubMed ID: 23161557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins.
    Kanakura Y; Druker B; Cannistra SA; Furukawa Y; Torimoto Y; Griffin JD
    Blood; 1990 Aug; 76(4):706-15. PubMed ID: 2166606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
    Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
    Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival.
    Hallsworth MP; Soh CP; Twort CH; Lee TH; Hirst SJ
    Am J Respir Cell Mol Biol; 1998 Dec; 19(6):910-9. PubMed ID: 9843925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
    Alsalameh S; Firestein GS; Oez S; Kurrle R; Kalden JR; Burmester GR
    J Rheumatol; 1994 Jun; 21(6):993-1002. PubMed ID: 7932447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.